The Safety and Efficacy of Routine Administration of Intracameral Vancomycin during Cataract Surgery
Table 3
Summary of the characteristics and outcomes of subjects developing postoperative endophthalmitis in the cohort that did not receive intracameral vancomycin.
Case ID
Age/gender
Complications during the cataract surgery
Complex cataract surgery billed
Previous ocular surgery
Underlying ocular comorbidities
Presentation of intraocular infection symptoms to clinician after cataract surgery
Presenting BSCVA (Snellen)
Eventual pars plana vitrectomy performed
Final BSCVA (Snellen)
1
72-year-old male
No
No
No
No
7 days
20/200
No
20/20
2
64-year-old female
No
No
Yes Eight incision radial keratotomy
No
4 days
20/400
No
20/20
3
74-year-old female
No
No
No
No
36 days
20/200
Yes
20/20
4
69-year-old male
No
Yes Trypan blue
Yes Penetrating keratoplasty for pellucid marginal degeneration
